Lisata Therapeutics, Inc. (LSTA) Q4 2024 Annual Earnings
LSTA·Reported February 27, 2025·After market close
Lisata Therapeutics, Inc. reported Q4 2024 revenue of $1.0M. Diluted EPS came in at $-0.55, beat the $-0.76 consensus by $0.21.
Revenue
$1.0M
Diluted EPS
$-0.55beat by $0.21
Consensus: $-0.76
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Lisata Therapeutics, Inc.'s Q4 2024 earnings report.
Lisata Therapeutics, Inc. (LSTA) reported Q4 2024 earnings on February 27, 2025 after market close.
Lisata Therapeutics, Inc. reported revenue of $1.0M and diluted EPS of $-0.55 for Q4 2024.
EPS beat the consensus estimate of $-0.76 by $0.21.
You can read the 10-K periodic report (0000320017-25-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.